Michel Barrot

Neurobiology of depression.

Regional and cellular mapping of cAMP response element-mediated transcription during naltrexone-precipitated morphine withdrawal.

CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli.

Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal.

Morphine acutely regulates opioid receptor trafficking selectively in dendrites of nucleus accumbens neurons.

RGS9 modulates dopamine signaling in the basal ganglia.

Phospholipase Cgamma in distinct regions of the ventral tegmental area differentially modulates mood-related behaviors.

Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression.

Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood.

The presynaptic active zone protein RIM1alpha is critical for normal learning and memory.

Essential role of brain-derived neurotrophic factor in adult hippocampal function.

Induction of deltaFosB in reward-related brain structures after chronic stress.

The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance.

Frontocortical 5-HT4 receptors exert positive feedback on serotonergic activity: viral transfections, subacute and chronic treatments with 5-HT4 agonists.

Regulation of anxiety and initiation of sexual behavior by CREB in the nucleus accumbens.

DeltaFosB accumulates in a GABAergic cell population in the posterior tail of the ventral tegmental area after psychostimulant treatment.

Regulation of drug reward by cAMP response element-binding protein: evidence for two functionally distinct subregions of the ventral tegmental area.

Inflammatory pain upregulates spinal inhibition via endogenous neurosteroid production.

Calibrated forceps: a sensitive and reliable tool for pain and analgesia studies.

Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors.

The transcription factor DeltaFosB is recruited by inflammatory pain.

Induction of deltaFosB in the periaqueductal gray by stress promotes active coping responses.

Delta-opioid receptors are critical for tricyclic antidepressant treatment of neuropathic allodynia.

Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy.

Sciatic nerve cuffing in mice: a model of sustained neuropathic pain.

Chronic, but not acute, tricyclic antidepressant treatment alleviates neuropathic allodynia after sciatic nerve cuffing in mice.

The influence of DeltaFosB in the nucleus accumbens on natural reward-related behavior.

Beta2-adrenoceptors are essential for desipramine, venlafaxine or reboxetine action in neuropathic pain.

CREB regulation of nucleus accumbens excitability mediates social isolation-induced behavioral deficits.

Afferents to the GABAergic tail of the ventral tegmental area in the rat.

beta(2)-adrenoceptors are critical for antidepressant treatment of neuropathic pain.

Differentiating thermal allodynia and hyperalgesia using dynamic hot and cold plate in rodents.

From antidepressant drugs to beta-mimetics: preclinical insights on potential new treatments for neuropathic pain.

gamma-Aminobutyric acid cells with cocaine-induced DeltaFosB in the ventral tegmental area innervate mesolimbic neurons.

Chronic treatment with agonists of beta(2)-adrenergic receptors in neuropathic pain.

Beta2-adrenoceptor agonists alleviate neuropathic allodynia in mice after chronic treatment.

Phosducin influences sympathetic activity and prevents stress-induced hypertension in humans and mice.

Mu-opioid receptors are not necessary for nortriptyline treatment of neuropathic allodynia.

Is there a place for beta-mimetics in clinical management of neuropathic pain? Salbutamol therapy in six cases.

Pharmacological recruitment of the GABAergic tail of the ventral tegmental area by acute drug exposure.

When chronic pain can suppress the opioid kick: new insights from preclinical research.

Cardiovascular effects of chronic treatment with a β2-adrenoceptor agonist relieving neuropathic pain in mice.

Nociceptive thresholds are controlled through spinal β2-subunit-containing nicotinic acetylcholine receptors.

A time-dependent history of mood disorders in a murine model of neuropathic pain.

Discovering a new anatomical structure in the brain: implications for neuropsychiatry and therapy.

Neuronal circuits underlying acute morphine action on dopamine neurons.

A new control center for dopaminergic systems: pulling the VTA by the tail.

Braking dopamine systems: a new GABA master structure for mesolimbic and nigrostriatal functions.

BDNF parabrachio-amygdaloid pathway in morphine-induced analgesia.

Daily methylphenidate and atomoxetine treatment impacts on clock gene protein expression in the mouse brain.

Antidepressants suppress neuropathic pain by a peripheral β2-adrenoceptor mediated anti-TNFα mechanism.

Clusters of cerebellar Purkinje cells control their afferent climbing fiber discharge.

The antiallodynic action of nortriptyline and terbutaline is mediated by β(2) adrenoceptors and δ opioid receptors in the ob/ob model of diabetic polyneuropathy.

Control of the Nigrostriatal Dopamine Neuron Activity and Motor Function by the Tail of the Ventral Tegmental Area.